Druggio Logo

Druggio

Ohara Pharmaceutical

Ohara Pharmaceutical is a Japan-based pharmaceutical company that was founded in 1952. The company focuses on the research, development, and production of pharmaceutical products, including drugs for various therapeutic areas such as digestive diseases, cardiovascular disorders, and central nervous system disorders. Their portfolio includes medications for conditions such as peptic ulcers, hypertension, and psychiatric disorders. Additionally, the company has a strong focus on innovative drug development and is committed to improving patient outcomes through their research and product development efforts.

Ohara Pharmaceutical's Drugs

Megludase

Approval date

2021/9/27

Unituxin

Approval date

2021/6/23

Erwinase

Approval date

2016/12/19